April 7, 2017
A forthcoming 28-patient study in the American Heart Association's journal Stroke shows that AiCure's artificial intelligence platform led to a 50 percent improvement in adherence to oral anticoagulants.
In the study, a cohort of 28 ischemic stroke survivors was followed for 12 weeks. Fifteen were assigned to the intervention group that used AiCure's software to monitor their adherence daily, and...
March 14, 2017
Digital health company Mango Health, which makes a gamified app for patient engagement and medication adherence, has announced a strategic investment from — and longterm partnership with — Express Scripts, the largest pharmacy benefit management organization in the United States. The amount of the investment was undisclosed.
Through the deal, Express Scripts’ 85 million clients will have access...
March 1, 2017
Medication adherence startup MediSafe has raised $14.5 million in a round led by Octopus Ventures and M Ventures (the venture arm of Merck Pharmaceuticals), with participation from existing investors Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures. The company also announced that it will begin expanding into Europe using some of the funds.
November 17, 2016
Correction: A previous version of this article misstated the adherence figure.
Adherium’s Smartinhaler has been shown to increase medication adherence by 43 percent and reduce hospitalization by a factor of five, according to a new study conducted at Sheffield Children’s Hospital in the UK and published in the journal Thorax. The randomized control trial included 77 children with asthma.
November 16, 2016
Around the world, pharmaceutical companies are losing $637 billion in revenue per year from a multifaceted, but common problem: people with chronic conditions are not adhering to their medication.
In a research paper by medication adherence company HealthPrize Technologies and consulting company Capgemini, the issue was described as “one of the most serious problems in healthcare,” affecting all...
November 14, 2016
Intent Solutions, an Atlanta-based company working on a connected medication dispenser called TAD, has raised $1.5 million in seed funding. The company did not disclose the investors.
"We have been quietly raising capital for several months while refining our technology and service offerings," Sam Zamarripa, president of Intent Solutions, said in a statement. "In that time, we've developed...
November 10, 2016
Medication adherence device maker PillDrill has secured $3 million in funding for its flagship product, also called PillDrill, and will be featured on the Consumer Technology Association’s website.
The device, which launched in April, consists of a compact scanning system called the PillDrillHub that is designed to sit next to the user’s pills. When doses are due, it sends out audio-visual alerts...
October 3, 2016
New York City based-startup Quio, which is working on a sensor-enabled drug injector and companion software for the clinical trial and chronic disease market, has raised $1.05 million in seed funding. The undisclosed investors include those with expertise in health insurance, pharmaceuticals and clinical research, the company revealed.
Quio is developing Smartinjector, a connected medication...
September 12, 2016
Today Walgreens shared new data from two studies that show the company's mobile tools -- both its mobile pill reminder and its Balance Rewards for Healthy Choices platform -- improve medication adherence for users.
“People increasingly want to become more engaged in their own health care, and with Walgreens digital health offerings, we give our customers the ability to positively impact their...
August 22, 2016
Proteus Digital Health is working with Children's Health in Dallas, Texas in one of the first trials of its ingestible sensor technology in pediatric patients, The Dallas Morning News reports.
The trial involves patients recovering from an organ transplant, a group that typically needs to take a lot of medications on a fairly strict schedule. Fifteen patients are using the Proteus platform now...